packageRavulizumab
ravulizumab
Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).
Information
Ravulizumab, a monoclonal antibody complement inhibitor, is used for paroxysmal nocturnal hemoglobinuria and is also studied or used for conditions such as myasthenia gravis, neuromyelitis optica, and atypical hemolytic uremic syndrome. It is an approved medicine, authorised in the European Union for paroxysmal nocturnal hemoglobinuria, and carries a boxed warning.
Summary written by glm-5.3-flash from Wikidata Q55641547 and the WHO ATC classification and the EMA medicines list; not checked by a person.
| name: | ravulizumab |
| ATC codes: | L04AA43, L04AJ02 |
| DrugBank: | DB11580 |
| Wikidata: | Q55641547 |
| molar mass: | 148000 g/mol (Drugs.Common 25.09, not verified) |
Parameters
| Type | Name | Default | Description |
|---|---|---|---|
| String | name (from PartialSubstance) | "" | INN / common name |
| String[:] | atcCodes (from PartialSubstance) | fill("", 0) | all WHO ATC codes of the drug |
| String | drugbankId (from PartialSubstance) | "" | e.g. DB00758 |
| String | pubchemCid (from PartialSubstance) | "" | PubChem compound id |
| String | chebiId (from PartialSubstance) | "" | ChEBI id (number) |
| String | wikidataId (from PartialSubstance) | "" | e.g. Q410238 |
| String | formula (from PartialSubstance) | "" | molecular formula |
| Modelica.Units.SI.MolarMass | M (from PartialSubstance) | 0 | molar mass; 0 = unknown |
| Real | logP (from PartialSubstance) | Modelica.Constants.inf | octanol-water partition coefficient (log10); inf = unknown |